JW (Cayman) Therapeutics Co. Ltd
HKEX:2126.HK
1.37 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2018 Q1 | 2017 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||
| Net Income
| -387.581 | -380.415 | -416.881 | -429.254 | -421.633 | -280.695 | -1,013.774 | -650.029 | -275.388 | -357.869 | -158.314 | -68.154 | -68.154 | -68.154 |
| Depreciation & Amortization
| 44.256 | 49.515 | 39.999 | 41.367 | 30.94 | 15.387 | 12.67 | 10.498 | 10.251 | 6.807 | 4.326 | 1.277 | 1.277 | 1.277 |
| Deferred Income Tax
| 0 | 0 | -19.47 | 0 | 3.397 | 0 | -75.824 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 3.011 | 31.954 | 33.532 | 48.97 | 25.387 | 63.983 | 76.779 | 57.471 | 15.443 | 0 | 3.861 | 0 | 0 | 0 |
| Change In Working Capital
| 3.188 | 0 | -25.095 | 0 | 49.785 | 0 | 16.671 | 0 | 11.883 | -30.758 | -4.719 | -0.049 | -0.049 | -0.049 |
| Accounts Receivables
| 5.305 | 0 | -5.305 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 5.381 | 0 | -8.757 | 0 | -28.784 | 0 | -0.955 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -7.498 | 0 | -11.033 | 0 | 78.569 | 0 | 17.626 | 0 | 11.883 | -30.758 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| 176.739 | 60.915 | 202.442 | -31.802 | 35.442 | -79.794 | 753.526 | 475.183 | 152.614 | 278.094 | 107.616 | 40.369 | 40.369 | 40.369 |
| Operating Cash Flow
| -160.387 | -238.031 | -166.003 | -370.719 | -280.079 | -281.119 | -154.128 | -106.877 | -85.197 | -103.726 | -47.231 | -26.557 | -26.557 | -26.557 |
| Investing Activities: | ||||||||||||||
| Investments In Property Plant And Equipment
| -5.648 | -6.761 | -49.9 | -26.974 | -36.022 | -37.065 | -46.596 | -77.642 | -83.468 | -18.478 | -28.517 | -11.037 | -11.037 | -11.037 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45.308 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -1.965 | 24.278 | 7.776 | -54.985 | -9.186 | -54.857 | -3.619 | -9.36 | -14.604 | -1.004 | 28.517 | 11.037 | 11.037 | 11.037 |
| Investing Cash Flow
| -7.613 | 17.517 | -42.124 | -81.959 | -45.208 | -91.922 | -50.215 | -41.694 | -98.072 | -19.482 | -29.389 | -11.037 | -11.037 | -11.037 |
| Financing Activities: | ||||||||||||||
| Debt Repayment
| 0 | -94.453 | 0 | -10.06 | 0 | -5.24 | 0 | -44.476 | 0 | -17.62 | -10.014 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | -0.001 | 0 | -0.683 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -88.622 | -5.556 | 125.035 | -2.62 | -7.54 | -17.158 | 2,108.901 | 706.05 | 58.742 | 372.927 | 10.014 | -9.094 | -9.094 | -9.094 |
| Financing Cash Flow
| -88.622 | 88.897 | 125.034 | -12.68 | -8.223 | -22.398 | 2,108.901 | 750.526 | 58.742 | 355.307 | -0.92 | -9.094 | -9.094 | -9.094 |
| Other Information: | ||||||||||||||
| Effect Of Forex Changes On Cash
| -10.362 | 21.174 | -53.302 | 150.69 | -38.432 | -28.818 | -134.157 | 3.376 | 6.208 | 7.423 | 107.84 | 74.803 | 74.803 | 74.803 |
| Net Change In Cash
| 0 | -110.443 | -136.395 | -314.668 | -371.942 | -424.257 | 1,770.401 | 605.331 | -118.319 | 239.522 | 30.301 | 28.115 | 28.115 | 28.115 |
| Cash At End Of Period
| 1,272.893 | 1,272.893 | 1,383.336 | 1,519.731 | 1,834.399 | 2,206.341 | 2,630.598 | 860.197 | 254.866 | 373.185 | 63.717 | 33.416 | 33.416 | 33.416 |